INVZ Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
INVZ is not a good buy right now for a beginner long-term investor with $50,000-$100,000 available. The stock is trading weakly, there is no strong proprietary buy signal, analyst sentiment has turned more cautious, and there are no recent news catalysts or insider/congress buying to support a fresh purchase. The best choice here is to hold off and avoid buying at this level.
The technical picture is mixed to weak. The stock is down sharply in the latest session, with regular market change at -8.86% and the close at 0.68285 below the previous close of 0.6927. MACD histogram is positive at 0.0168 but is contracting, which suggests fading upward momentum. RSI_6 at 57.4 is neutral, so there is no strong oversold bounce signal. Moving averages are converging, indicating a lack of clear trend direction. Key levels to watch are pivot 0.66, resistance 0.764, and support 0.557. Overall, the current trend is not strong enough to justify a confident long-term entry now.
The only meaningful positive catalyst is the very bullish call-heavy options positioning. Technical support sits near 0.66, close to the current price, which could provide a near-term floor. The MACD histogram is still above zero, so there is at least some residual positive momentum.
There is no recent news in the last week, so no fresh event-driven catalyst is visible. Goldman Sachs recently downgraded Innoviz to Neutral from Buy and cut the price target to 75c from $1.25, citing weaker momentum and disappointment that the company’s development work with a top OEM has not yet translated into a production award. The stock also suffered a very sharp daily decline. There are no notable hedge fund, insider, politician, or congress buying trends to support the name.
No usable latest-quarter financial snapshot was provided, so quarterly revenue or earnings growth cannot be assessed from the available data. Because the financials are missing, there is no evidence here to support a long-term fundamental buy case.
Analyst sentiment is negative to cautious. Goldman Sachs downgraded INVZ to Neutral from Buy and reduced the price target from $1.25 to 75c on 2026-04-13, then reiterated Neutral and kept the 75c target on 2026-04-14. The firm said competitors appear to have better momentum and that expected conversion of the OEM development work into a series production award has not materialized. Wall Street pros are therefore leaning cautious rather than bullish.
